Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$76,850,909
+$51,318,992 QoQ
Shares Held
410,353
+56.3% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
19.72%
of 13F equity value
Holder Rank
#72
of 686 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Checkpoint Capital L.P. holds $389,759,659 across 6 Biotechnology names. RVMD ranks #3 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,186,000 | $131,681,580 | |
| 2 | ARGX |
Argenx SE
|
131,283 | $121,800,428 | |
| 3 | RVMD |
Revolution Medicines, Inc.
This page
|
410,353 | $76,850,909 | |
| 4 | CYTK |
Cytokinetics Inc
|
475,000 | $40,465,250 | |
| 5 | IRON |
Disc Medicine, Inc.
|
240,125 | $17,562,742 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
75,000 | $1,398,750 |
All Filings in RVMD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,850,909 | 410,353 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,531,917 | 262,539 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $29,470,500 | 370,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $22,990,410 | 492,300 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,301,200 | 280,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,861,508 | 392,011 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,185,400 | 210,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||